Cite
HARVARD Citation
Sharma, P. et al. (n.d.). Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial. Lancet oncology. 17 (11), pp. 1590-1598. [Online].